Search

Home > Zacks Stocks In The News > Gilead Buys Kite, the Future of CAR-T, and A Visit to the New Whole Foods
Podcast: Zacks Stocks In The News
Episode:

Gilead Buys Kite, the Future of CAR-T, and A Visit to the New Whole Foods
Category: Business
Duration: 00:27:09
Publish Date: 2017-09-01 10:31:33
Description:

Ryan McQueeney and Maddy Johnson take on this week’s biggest stories, including Gilead’s acquisition of Kite Pharma, the future of the CAR-T therapy industry, and Amazon’s changes to Whole Foods stores. Please pick a time stamped topic below:

(0:35) - Hurricane Harvey and North Korea Tensions

(2:30) - Gilead's Acquisition of Kite Pharma: What Is CAR-T Therapy?

(4:45) - Novartis CAR-T Cell Therapy Receives Approval By FDA

(6:50) - CAR-T Biotech Stocks On The Rise

(10:40) - Is This A New Era For Biotech

(15:15) - Price Cutting On Whole Foods Products

(19:20) - Amazon Echoes and Instacart In-direct Competition

(23:45) - Upcoming Rewards Program For Prime Members

(26:00) - Episode Roundup: Podcast@Zacks.com

Make sure to subscribe and leave the show a rating on iTunes!
Total Play: 0

Users also like

800+ Episodes
GuerrillaFM 1K+     50+

Some more Podcasts by Zacks Investment Research

100+ Episodes
Spoken Word 5     1
200+ Episodes
Value Invest .. 10+     1
100+ Episodes
ETF Spotligh ..     1